Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
International Journal of Medical Informatics
|
May 22, 2018
The impact of using an intravenous workflow management system (IVWMS) on cost and patient safety
Alex C Lin, Yihong Deng, Hilal Thaibah, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
June 5, 2016
Risk factors for i.v. compounding errors when using an automated workflow management system
Yihong Deng, Alex C Lin, John Hingl, et al.
Annals of the American Thoracic Society
|
May 9, 2020
Methodological Quality of Systematic Reviews and Meta-Analysis on Asthma Treatments. A Cross-Sectional Study
Irene X Y Wu, Yihong Deng, Huan Wang, et al.
Analytical Biochemistry
|
July 4, 2016
Characterization of protein expression levels with label-free detected reverse phase protein arrays
Xuexue Guo, Yihong Deng, Chenggang Zhu, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
January 20, 2025
Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk
Rozalina G McCoy, Kavya Sindhu Swarna, Joshua J Neumiller, et al.
JAMA Internal Medicine
|
June 21, 2021
Levothyroxine Use in the United States, 2008-2018
Juan P Brito, Joseph S Ross, Omar M El Kawkgi, et al.
JAMA Network Open
|
February 1, 2021
Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
Rozalina G McCoy, Holly K Van Houten, Yihong Deng, et al.
Journal of Biomedical Nanotechnology
|
September 10, 2015
Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption
Chunhui Chen, Xi Zhu, Yanfeng Dou, et al.
Journal of the American Heart Association
|
July 17, 2025
Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk
Yihong Deng, Eric C Polley, Jeph Herrin, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
May 17, 2021
Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
Nicholas Y Tan, Yihong Deng, Xiaoxi Yao, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
International Journal of Medical Informatics
|
May 22, 2018
The impact of using an intravenous workflow management system (IVWMS) on cost and patient safety
Alex C Lin, Yihong Deng, Hilal Thaibah, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
June 5, 2016
Risk factors for i.v. compounding errors when using an automated workflow management system
Yihong Deng, Alex C Lin, John Hingl, et al.
Annals of the American Thoracic Society
|
May 9, 2020
Methodological Quality of Systematic Reviews and Meta-Analysis on Asthma Treatments. A Cross-Sectional Study
Irene X Y Wu, Yihong Deng, Huan Wang, et al.
Analytical Biochemistry
|
July 4, 2016
Characterization of protein expression levels with label-free detected reverse phase protein arrays
Xuexue Guo, Yihong Deng, Chenggang Zhu, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
January 20, 2025
Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk
Rozalina G McCoy, Kavya Sindhu Swarna, Joshua J Neumiller, et al.
JAMA Internal Medicine
|
June 21, 2021
Levothyroxine Use in the United States, 2008-2018
Juan P Brito, Joseph S Ross, Omar M El Kawkgi, et al.
JAMA Network Open
|
February 1, 2021
Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
Rozalina G McCoy, Holly K Van Houten, Yihong Deng, et al.
Journal of Biomedical Nanotechnology
|
September 10, 2015
Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption
Chunhui Chen, Xi Zhu, Yanfeng Dou, et al.
Journal of the American Heart Association
|
July 17, 2025
Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk
Yihong Deng, Eric C Polley, Jeph Herrin, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
May 17, 2021
Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
Nicholas Y Tan, Yihong Deng, Xiaoxi Yao, et al.
Page
of 5